|Bid||8.48 x 0|
|Ask||8.49 x 0|
|Day's Range||8.42 - 8.63|
|52 Week Range||5.09 - 24.10|
|Beta (5Y Monthly)||3.23|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.34|
Announced a manufacturing agreement with The Valens Company Inc. a leading manufacturer of cannabis ...
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a manufacturing agreement with The Valens Company Inc. ("The Valens Company" or "Valens") a leading manufacturer of cannabis products, to manufacture a new seasonal offering in the mint category.
In my view, investors should probably avoid buying shares of Sundial Growers (NASDAQ: SNDL) and Aurora Cannabis (NASDAQ: ACB). Neither of the Canadian marijuana companies is profitable, and both reported plummeting quarterly revenue in their most recent earnings update. Aurora's financial strength is especially poor.